EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia ,

ISSN 2394-3211

Impact Factor: 7.065

ICV - 79.57

Abstract

A REVIEW ON PARKINSON’S DISEASE

Shahbaz Ahmad*, Pritt Verma, Amresh Gupta, Amit K. Srivastava and Om Prakash Verma

ABSTRACT

Parkinson's disease is a common movement condition seen in neurology, but it's difficult to diagnose and treat. Since PD patients experience a wide range of motor and non-motor symptoms, the diagnosis is clinical and can be challenging. The medical care of Parkinson's disease patients is complicated due to a shortage of drug options and the use of levodopa as the mainstay of treatment. However, in Parkinson's disease patients taking levodopa, levodopa induced dyskinesia (LID) is normal. This is a typical side effect that occurs after a long period of treatment, but it may also occur after a few days or months of treatment. Different surgical techniques, such as unilateral pallidotomy and deep brain stimulation, have shown outstanding results in PD patients who are unable to control their symptoms with drugs alone.

Keywords: Deep brain stimulation, dopaminergic medications, Parkinson's disease.

[Full Text Article] [Download Certificate]